US 12,129,511 B2
Methods for isolating target analytes from biological samples using ATPS and solid phase media
Cheuk Yiu Tenny Chung, Hong Kong (CN); Vasu Saini, Hong Kong (CN); Daniel William Bradbury, Hong Kong (CN); Harsha Madan Kittur, Singapore (SG); Masae Kobayashi Wen, Buena Park, CA (US); Cheuk Yin Lam, Hong Kong (CN); Kar Kee Tse, Hong Kong (CN); Kit Cheung, Hong Kong (CN); Wing Yee Ng, Hong Kong (CN); Yin To Chiu, Hong Kong (CN); and Garrett Lee Mosley, Hong Kong (CN)
Assigned to PHASE SCIENTIFIC INTERNATIONAL, LTD., Hong Kong (CN)
Filed by Phase Scientific International, Ltd., Hong Kong (CN)
Filed on Sep. 8, 2023, as Appl. No. 18/463,313.
Claims priority of provisional application 63/381,932, filed on Nov. 2, 2022.
Claims priority of provisional application 63/381,933, filed on Nov. 2, 2022.
Prior Publication US 2024/0141409 A1, May 2, 2024
Int. Cl. C12Q 1/6806 (2018.01); C12Q 1/70 (2006.01)
CPC C12Q 1/6806 (2013.01) [C12Q 1/70 (2013.01)] 30 Claims
 
1. A method for concentrating and purifying at least one target analyte from a clinical biological sample, comprising the steps of
(a) combining the clinical biological sample with a first aqueous two-phase system (ATPS) composition comprising a polymer, a salt component comprising at least one salt, a surfactant, or any combination thereof dissolved in an aqueous solution to form a target-rich phase solution and a target-poor phase solution, such that the target analyte is concentrated in the target-rich phase;
(b) collecting the target-rich phase;
(c) optionally adding the target-rich phase to a second ATPS composition comprising a polymer, a salt component comprising at least one salt, a surfactant, or any combination thereof dissolved in an aqueous solution to form a second target-rich phase solution and a second target-poor phase solution, such that the target analyte is concentrated in the second target-rich phase, and collecting the second target-rich phase;
(d) optionally mixing the target-rich phase from step (b) or the second target-rich phase from step (c) with a binding buffer to form a mixed solution;
(e) contacting the target rich phase from step (b), the second target-rich phase from step (c) or the-mixed solution from step (d) with a solid phase medium configured to selectively bind the target analyte such that the solid phase medium binds to the target analyte; and
(f) eluting and collecting the target analyte from the solid phase medium with an eluting solution, resulting in a final solution containing the concentrated and purified target analyte.